EU Industry Chief Warns Against Overreliance on Single Country Supply Chains Tokenization Could Allow Investors to Shop for Yield Says Strategys Michael Saylor Meta Settles Social Media Addiction Lawsuit Filed by US School District Averting Test Case for 1200 Similar Claims Crude Oil Retreats as ProfitTaking and Consumer Demand Concerns Weigh 3M India Proposes Special Dividend of 506 Per Share Reports Strong Quarterly Profit Surge AGX Files Lawsuit Against RR and Huntington Over Frozen Credit Line and Unpaid Carrier Invoices SMR Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Phase Pagaya Technologies PGY Q1 2026 Earnings Massive EPS Surprise Masks Mixed Operational Signals AEON Biopharma Inc AEON Q4 2025 Earnings Significant EPS Miss and Stock Decline Amid Development Challenges TNDM Q1 2026 Earnings Narrowing Loss Surpasses Expectations Stock Dips on Cautious Outlook Elevance Health Q1 2026 Earnings Strong EPS Beat Amidst Market Caution OppFi Q1 2026 Earnings EPS Beat Drives Positive Momentum Despite Stock Pullback Riskified Ltd RSKD Edges Higher as Investors Eye Key Resistance Near 503 INNOVATE Corp VATE Gains 374 as Price Approaches Key Resistance Level eToro Group ETOR Gains Ground Testing Resistance After 313 Rally NeOnc Technologies Holds Ground Near Key Support Amid Biotech Uncertainty NTHI BranchOut Food Inc BOF Edges Higher as Stock Holds Above Key Support Level Former JPMorgan Bankers Legal Counsel Withdraws Just Before Scheduled Court Hearing PSQ Holdings Q1 2026 Earnings EPS Surpasses Estimates Shares Rise Gibraltar Industries ROCK Holds Steady Near Support Amid Modest Decline Canada Goose GOOS Q1 2026 Earnings EPS Miss Amidst Quiet Market Response INLX Q1 2026 Earnings Significant EPS Miss Raises Concerns MLSS Q1 2026 Earnings NarrowerThanExpected Loss Per Share LifeMD Q1 2026 Earnings EPS Beats Estimates by 1166 as Stock Rises 119 Mattel Q1 2026 Earnings NarrowerThanExpected Loss Amid Cost Discipline Accendra Health Inc ACH Q1 2026 Earnings EPS Beats Estimates with a 609 Surprise as Narrower Loss Fuels Investor Optimism ELVN Q1 2026 Earnings NarrowerthanExpected Loss as PreRevenue Biotech Advances Pipeline